Search over 500 companies covered in the blog

Custom Search

Subscribe to any international magazine for free

For subscription

For investment ideas subscription queries you can mail me at" arunanalyst@rediffmail.com".Its all about investment ideas for the medium to long term.No intraday or trading stuff do keep that in mind.To deposit the fees you can do online fund transfer,cash deposit,cheque deposit in either of the below mentioned accounts:-

Name:Partha Pratim Mukhopadhyay, ICICI Bank, Account no:000601016473, Branch:Calcutta
Name:Arun Kumar Mukherjee, Axix/uti Bank, Account no:033010100490191, Branch:Konnagar

Sunday, November 8, 2009

Venus Remedies Ltd:Future growth outlook and prosepects,buy/sell/hold

Scripscan:Venus Remedies Ltd
cmp:210
Code:526953

Story:Venus Remedies Limited engages in the research, development, manufacture, and marketing of pharmaceutical formulations in India and internationally. It primarily manufactures oncological and cephalosporin injectable products. The company provides oncology liquid injections, oncology lyophilized injections, pre-filled syringes, cephalosporins, carbapenems, and cardiology injections and liquid vials. The company, formerly known as Venus Glucose Pvt. Limited, was founded in 1989 and is headquartered in Panchkula, India.Venus reported a muted growth of 1% in revenues during Q4FY09 to Rs 634 million. On QoQ basis, revenue de-grew by 3%. Lower growth in revenue is mainly because of muted growth in exports and slow off-take (decline of 13% QoQ) by strategic partners in the domestic market. On the operating front, EBIDTA declined by 11% to Rs 149 million in Q4FY09 (Rs 167million in Q4FY08). We are also introducing FY11E estimates (EPS of Rs 69.3 in FY11E). At CMP of Rs 210,the stock is trading at 3.9x FY10E EPs of Rs 54.5. We maintain buy with a target price of Rs 275 4.4x rolling EPS of Rs 61.9.
Posted by arun at 7:17 AM
Your Ad Here
Custom Search

Important Disclaimer

Investment in equity shares has its own risks.Sincere efforts have been made to present the right investment perspective.The information contained herein is based on analysis and up on sources that I consider reliable. I,however,do not vouch for the accuracy or the completeness thereof.This material is for personal information and am not responsible for any loss incurred based upon it & take no responsibility whatsoever for any financial profits or loss which may arise from the recommendations above.The stock price projections shown are not necessarily indicative of future price performance.The information herein, together with all estimates and forecasts, can change without notice.